Divi's Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Divi's Laboratories has a total shareholder equity of ₹126.8B and total debt of ₹50.0M, which brings its debt-to-equity ratio to 0.04%. Its total assets and total liabilities are ₹142.8B and ₹16.1B respectively. Divi's Laboratories's EBIT is ₹15.9B making its interest coverage ratio -7.8. It has cash and short-term investments of ₹36.1B.
Key information
0.04%
Debt to equity ratio
₹50.00m
Debt
| Interest coverage ratio | -7.8x |
| Cash | ₹36.11b |
| Equity | ₹126.77b |
| Total liabilities | ₹16.06b |
| Total assets | ₹142.83b |
Recent financial health updates
No updates
Recent updates
Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price
Apr 19
Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar
Dec 27Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00
Aug 04Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00
Jul 20Divi's Laboratories (NSE:DIVISLAB) Has Announced A Dividend Of ₹30.00
Jul 06Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?
Nov 08Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00
Aug 04Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 21Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00
Jul 07Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today
Jul 03Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?
Apr 03Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?
Dec 23With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting
Sep 02Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Is Well Worth Watching
Mar 25Do Institutions Own Divi's Laboratories Limited (NSE:DIVISLAB) Shares?
Mar 10Who Has Been Selling Divi's Laboratories Limited (NSE:DIVISLAB) Shares?
Feb 23Is Divi's Laboratories' (NSE:DIVISLAB) Share Price Gain Of 216% Well Earned?
Jan 25
Is Divi's Laboratories Limited's(NSE:DIVISLAB) Recent Stock Performance Tethered To Its Strong Fundamentals?
Jan 07Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?
Dec 20What Type Of Shareholders Own The Most Number of Divi's Laboratories Limited (NSE:DIVISLAB) Shares?
Dec 03Financial Position Analysis
Short Term Liabilities: DIVISLAB's short term assets (₹88.8B) exceed its short term liabilities (₹10.1B).
Long Term Liabilities: DIVISLAB's short term assets (₹88.8B) exceed its long term liabilities (₹6.0B).
Debt to Equity History and Analysis
Debt Level: DIVISLAB has more cash than its total debt.
Reducing Debt: DIVISLAB's debt to equity ratio has reduced from 1.4% to 0.04% over the past 5 years.
Debt Coverage: DIVISLAB's debt is well covered by operating cash flow (30254.6%).
Interest Coverage: DIVISLAB earns more interest than it pays, so coverage of interest payments is not a concern.